Long-term Study of KAD-1229 in Type 2 Diabetes Patients

Clinical trial NCT01333592 · COMPLETED

Trial details

NCT number: NCT01333592
Sponsor: Kissei Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes

Primary completion: 2012-08-01
Enrollment: 136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.